The impact of curative conversion therapy aimed at a cancer-free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

导出 LinkOut

翻译打印收藏纠错

第一作者： Shigeo,Shimose

第一单位： Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.

作者： Shigeo,Shimose ^[1] ; Hideki,Iwamoto ^[1] ; Tomotake,Shirono ^[2] ; Masatoshi,Tanaka ^[1] ; Takashi,Niizeki ^[3] ; Masahiko,Kajiwara ^[1] ; Satoshi,Itano ^[4] ; Yoichi,Yano ^[5] ; Satoru,Matsugaki ^[6] ; Etsuko,Moriyama ^[7] ; Yu,Noda ^[1] ; Masahito,Nakano ^[1] ; Ryoko,Kuromatsu ^[1] ; Hironori,Koga ^[1] ; Takumi,Kawaguchi ^[1]

作者单位： Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan. ^[1] Iwamoto Internal Medical Clinic, Kitakyusyu, Japan. ^[2] Yokokura Hospital, Clinical Research Center, Miyama, Fukuoka, Japan. ^[3] Department of Gastroenterology, Chikugo City Hospital, Chikugo, Japan. ^[4] Department of Gastroenterology, Kurume Central Hospital, Kurume, Japan. ^[5] Division of Gastroenterology, Department of Medicine, Japan Community Health Care Organization, Saga Central Hospital, Saga, Japan. ^[6] Department of Gastroenterology, Tobata Kyoritsu Hospital, Kitakyusyu, Japan. ^[7]

关键词 atezolizumab plus bevacizumab conversion therapy hepatocellular carcinoma

主题词人类(Humans);癌, 肝细胞(Carcinoma, Hepatocellular);肝肿瘤(Liver Neoplasms);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome);化学栓塞, 治疗性(Chemoembolization, Therapeutic)

DOI 10.1002/cam4.5931

PMID 37062077

发布时间 2023-06-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Cancer medicine

2023年12卷11期

12325-12335页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

The impact of curative conversion therapy aimed at a cancer-free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Cancer medicine

相似文献

Cancer medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The impact of curative conversion therapy aimed at a cancer-free state in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.

Cancer medicine

相似文献

Cancer medicine

相关期刊

检索历史清除